Pathomorphological and Differential Diagnostic Features of Canine Splenic Lymphoma
DOI:
https://doi.org/10.31279/2949-4796-2025-15-2-25-41Keywords:
Canine spleen lymphoma, immunoblast, paraimmunoblast, spleen pathomorphological changes, lymphocyte, nucleola, chromatinDownloads
Abstract
Introduction. The lack of veterinary histological classifications based on tumor histogenesis complicates the morphological diagnosis of canine lymphoma. Diagnostic challenges primarily arise from: (1) the diversity of cellular variants originating from cells at different differentiation stages, (2) the common origin of lymphoid cells, and (3) multiple etiological factors in tumor development. This necessitates a comprehensive study of various lymphoma morphological types to identify their differential diagnostic features and histogenetic origins.
Aim. To develop a scientifically grounded approach for morphological diagnosis of canine lymphomas based on the principle of cellular histogenesis.
Materials and Methods. Histological blocks containing canine spleen tissue were selected. Tissue sections were prepared using microtomy and stained with hematoxylin and eosin. Specimens were examined via direct microscopy.
Results. Fifty canine spleens were analyzed. Fifteen specimens exhibited lymphoma structures, including: 4 small lymphocyte lymphomas; 9 B-cell large cell lymphomas; 1 lymphoplasmacytic lymphoma; 1 marginal zone lymphoma. Distinct morphological features of lymphomas were identified.
Conclusion. Histological evaluation incorporating histogenesis analysis, cellular composition and tumor growth patterns enables accurate diagnosis of lymphoproliferative disorders in animals. This approach is critical for disease prognosis and therapeutic decision-making in veterinary oncology.
References
Stepanova Yu.A., Ionkin D.A., Alimurzayeva M.Z., Kalinin D. V., Shirokov V. S., Ruchkin D.V. Primary extranodal lymphoma: stomach and spleen combined lesion. Diagnostic & interventional Radiology. 2020;14(3):81-90. (In Russ.) https://doi.org/10.25512/DIR.2020.14.3.09
Dudin, P.V. et al. Comparative efficacy of CHOP Madison Wisconsin and COP chemotherapy protocols in the treatment of b-cell lymphoma in dogs. Actual Questions of Veterinary Biology. 2024;1(61):36-39. (In Russ.) https://doi.org/10.24412/2074-5036-2024-161-36-39 EDN VWXTAY
Lagarnikova E.A., Shiman I.N., Menshikov E.V., Frants D.A., Chaichenko D.V., Chaban T.Ya., Khudyakov R.I., Pereveslov M.A. Primary non-Hodgkin's follicular and B-cell lymphoma of the spleen. Bulletin of the Chelyabinsk Regional Clinical Hospital. 2009;3(6):21-22. (In Russ.) EDN: YIMRXP
Nikiforov V.S., Svistov A.S., Bogdanov A.N., Reshetnev V.G., Voloshin S.V. Diagnosis of splenic non-hodgkin lymphoma. Clinical Medicine. 2009;87(2):67-69. (In Russ.) EDN: KGWKDN
Al-radi L.S., Moiseeva T.N., Julakyan U.L., et al The experience of studying lymphoma of the red pulp of the spleen. Therapeutic Archive. 2016;88(4):53-60. (In Russ.) https://doi.org/10.17116/terarkh201688453-60
Khvastunova A.N., Al-Radi L.S., Fedyanina O.S., Julhakyan U.L., Kapranov N.M., Zakirova A.O., Lugovskaya S.A., Naumova E.V., Ataullakhanov F.I., Kuznetsova S.A. Determination of morphology and immunophenotype of circulating lymphoma cells in patients with splenic marginal zone lymphoma using an anti-CD antibody microarray. Oncohematology. 2017;12(1):71-77. (In Russ.) https://doi.org/10.17650/1818-8346-2017-12-1-71-77
Poddubnaya I.V., Babicheva L.G. Diffuse large B-cell lymphoma and follicular lymphoma: problem state in Russia. Journal of Modern Oncology. 2024;26(2):140-148. (In Russ.) https://doi.org/10.26442/18151434.2023.2.202237
Babicheva L.G., Poddubnaya I.V. Heterogeneous diffuse large B-cell lymphoma: accurate diagnosis as a key to successful therapy. Journal of Modern Oncology. 2023;25(2):168-177. (In Russ.) https://doi.org/10.26442/18151434.2023.2.202237
Bialik T.E., Zaritsky A.Yu., Iseber L. Chronic lymphocytic leukemia / lymphoma from small lymphocytes. Clinical recommendations / Association of Oncologists of Russia, National Hematology Society, Russian Professional Society of Oncogematologists. 2020;64. (In Russ.) EDN FQEXDK
Silin A.P., Petrunko O.V., Sedova G.I., et al. The case of a combination of diffuse lymphoplasmocytic lymphoma with hypernephroid kidney cancer. Siberian Medical Journal. 1999;17(2):47-48. (In Russ.) EDN QZVIDB
Gorodetsky V.R., Probatova N.A., Tupitsyn N.N., Varlamova E.Yu., Kondratieva T.T., Balakireva T.V., Sholokhova E.N., Saridi E.Yu. Immunoglobulin-secreting lymphoma from cells of the marginal zone of the spleen (clinical and immunomorphological characteristics). Journal of Modern Oncology. 2000;2(4):141-146. (In Russ.)
Julakyan U.L., Biderman B.V., Gemjian E.G., Sudarikov A.B., Savchenko V.G Molecular analysis of immunoglobulin genes in the tumor B cells in splenic marginal zone lymphoma. Therapeutic Archive. 2015;87(7):58-63. (In Russ.) https://doi.org/10.17116/terarkh201587758-63
Ingle SB, Hinge CR. Primary splenic lymphoma: Current diagnostic trends. World Journal of Clinical Cases. 2016;4(12):385-389. https://doi.org/10.12998/wjcc.v4.i12.385
Mazurov V. I., Krivolapov Yu.A. Classification of lymphomas. Morphology, immunophenotype, and molecular genetics of non-Hodgkin lymphomas. Practical oncology. 2004;5(3):169-175. (In Russ.) EDN QIKTQP
Gorodetsky V.V., Probatova N.A., Tupitsin N.N. Immunoglobulin-secreting lymphoma from cells of the marginal zone of the spleen. Hematology and transfusiology. 2000;45(5):3-6. (In Russ.) EDN MPFILX
Tumyan G.S., Osmanov E.A., Kravchenko S.K. Aggressive non–follicular lymphomas - diffuse large-cell B-cell lymphoma, primary mediastinal B-cell lymphoma, Burkitt's lymphoma: Clinical recommendations. Moscow: Ministry of Health of the Russian Federation, 2020. (In Russ.) EDN MDHNMY
Guo Y., Lan X., Zhao H. Dural plasmacytoma as the initial presentation of multiple myeloma: A case report and review of the literature. Current Problems in Cancer. 2021;45(3):100672. https://doi.org/10.1016/j.currproblcancer.2020.100672 EDN LTLXLO
Sharafislamova M.B., Shabalina E.V., Milaev V.B. Cats’ and dogs’ treatment of lymphomas. Bulletin of the Izhevsk State Agricultural Academy. 2020;3(63):24-31. (In Russ.) EDN PSWWHR
Smykova O.G., Lepik K.V., Mikhailova N.B. Nivolumab-based immunotherapy in relapsed/refractory B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma. Cellular Therapy and Transplantation. 2021;10(1):37-43. https://doi.org/10.18620/ctt-1866-8836-2021-10-1-37-43 EDN WAZGDN
Kozlov A.V., Valiev T.T., Uldasheva S.A., et al. Successful treatment of relapsed/refractory anaplastic large cell lymphoma in adolescent patient: a case report. Cellular Therapy and Transplantation. 2022;11(3-4):77-82. https://doi.org/10.18620/ctt-1866-8836-2022-11-3-4-77-82 EDN RDOZZQ
Rukavitsyn O.A., Udalyeva V.Yu., Ageeva T.A., et al. Hematology: National guidelines. 2nd edition, revised and expanded. Limited Liability Company Publishing Group GEOTAR-Media, 2024;916. https://doi.org/10.33029/9704-8188-2-GEM-2024-1-916 (In Russ.) EDN CELAAZ
Published
Issue
Section
License
Copyright (c) 2025 Natalia V. Mitrokhina, Larisa F. Sotnikova
This work is licensed under a Creative Commons Attribution 4.0 International License.
